Ultragenyx Pharmaceutical Inc. (RARE) Profit Margin
Ultragenyx Pharmaceutical Inc. (RARE) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -184867.67% |
| 2017-12-31 | -11567.34% |
| 2018-12-31 | -383.75% |
| 2019-12-31 | -388.31% |
| 2020-12-31 | -68.84% |
| 2021-12-31 | -129.20% |
| 2022-12-31 | -194.71% |
| 2023-12-31 | -139.70% |
| 2024-12-31 | -101.61% |
| 2025-12-31 | -85.44% |
How RARE compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| IONS | Ionis Pharmaceuticals Inc. | -40.41% |
| OSUR | OraSure Technologies Inc. | -59.76% |
| QTRX | Quanterix Corporation | -77.14% |
| VNDA | Vanda Pharmaceuticals Inc. | -102.02% |
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
These are five companies in the same sector as RARE with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("RARE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RARE | $26.80 | +3.43% | 2.36M |
| 3 | ||||
| 4 | ||||
| 5 |